STEM CELLS, published by Oxford University Press, is a leading academic journal dedicated to advancing the field of cell and developmental biology. With an impressive impact factor and ranking in the Q1 and Q2 quartiles across various disciplines, including Developmental Biology and Molecular Medicine, this journal serves as a critical platform for disseminating cutting-edge research findings from 1981 to the present. The journal's rigorous peer-review process ensures the highest quality of published content, making it an essential resource for researchers, healthcare professionals, and students interested in the latest breakthroughs in stem cell research and its applications. With a focus on innovative methodologies and holistic perspectives, STEM CELLS not only highlights significant discoveries but also fosters a collaborative exchange of ideas, driving forward the frontiers of science in regenerative medicine and developmental studies.

CELL AND TISSUE RESEARCH, published by Springer, is a premier journal dedicated to advancing the field of cell biology, histology, pathology, and forensic medicine. With a proud history dating back to its foundation in 1924 and continuing its legacy, this journal has established itself as a vital source for innovative research, facilitating the dissemination of significant findings that contribute to the understanding of cellular and tissue dynamics. Hailing from Germany, the journal exhibits an impressive standing in the academic community with a 2023 impact factor reflected in its category quartiles: Q2 in Cell Biology, Q1 in Histology, and Q1 in Pathology and Forensic Medicine. It ranks notably within multiple Scopus categories, including 32/208 in Pathology and Forensic Medicine and 13/62 in Histology, showcasing its high percentile rankings of 84th and 79th, respectively. Researchers, professionals, and students benefit from its extensive coverage and rigorous peer-review process that ensures the integrity and relevance of its published works, thus making it an essential resource in the scientific community. While it operates under a subscription model, its commitment to quality and impact makes it an indispensable journal for anyone engaged in cellular and tissue research.

Inflammation and Regeneration is a prominent open-access journal published by BMC, focused on the discerning fields of immunology, cell biology, and regenerative medicine. Since its establishment in 2016, the journal has provided a platform for the dissemination of high-quality research, contributing significantly to the advancement of knowledge in inflammation processes and regenerative therapies. With a remarkable impact reflected in its Q1 quartile rankings in Cell Biology and Immunology for 2023, Inflammation and Regeneration stands out as a leading resource for researchers and practitioners. The journal's commitment to open access ensures that critical findings are readily available to a global audience, fostering collaboration and innovation in the scientific community. With a Scopus ranking that places it in the top 20% of its categories, Inflammation and Regeneration serves as an essential reference for those seeking to stay at the forefront of immunological research and its applications.

Regenerative Engineering and Translational Medicine is an esteemed academic journal published by Springer Heidelberg, focusing on the interdisciplinary fields of biomaterials, biomedical engineering, and cell biology. With an ISSN of 2364-4133 and an E-ISSN of 2364-4141, the journal has carved a niche for itself since its inception in 2015, showcasing cutting-edge research that bridges the gap between scientific findings and practical applications in regenerative medicine. As a recognized platform in its field, it is currently positioned within Q3 quartiles in biomaterials, biomedical engineering, and medicine (miscellaneous), with a Scopus ranking that reflects its growing influence among peers. The journal aims to disseminate high-quality, peer-reviewed articles that highlight advancements in regenerative engineering, further advancing both theoretical and applied research. Scholars and practitioners seeking to stay at the forefront of the ever-evolving landscape of regenerative health solutions will find invaluable insights and innovations within these pages. Join a community of leading thinkers and explore the journal's comprehensive research contributions, which are crucial for fostering partnerships between academia and industry in the quest for transformative medical solutions.

NEUROCHEMISTRY INTERNATIONAL, published by Pergamon-Elsevier Science Ltd, offers a premier platform for researchers and professionals in the realms of cell biology and cellular and molecular neuroscience. Established in 1980 and continuing its passion for advancing the field, this esteemed journal enhances scientific collaboration with a notable 2023 Q2 ranking in both relevant categories, placing it among the top-tier publications in its discipline with a Scopus rank of 23/97 for Cellular and Molecular Neuroscience. With its focus on groundbreaking research, the journal provides a wealth of vital data and insights that drive forward our understanding of neurochemistry and its implications in health and disease. While not an Open Access journal, NEUROCHEMISTRY INTERNATIONAL is integral for professionals, academics, and students aiming to stay at the forefront of neurobiological research innovations, making significant contributions to both academia and clinical applications.

DIFFERENTIATION is a respected peer-reviewed journal published by Elsevier Science Ltd, dedicated to advancing knowledge in the fields of Cancer Research, Cell Biology, Developmental Biology, and Molecular Biology. With an established history since 1973, the journal continuously explores the intricacies of cellular and molecular processes that govern differentiation in biological systems, thus playing a pivotal role in shaping contemporary research directions. Currently indexed in the Q3 quartile across multiple relevant categories, it provides a crucial platform for researchers to disseminate their findings and engage with the scientific community. DIFFERENTIATION does not offer open access, but it remains a valuable resource for academics seeking to enhance their understanding of the fundamental mechanisms that underpin life sciences. By fostering a rigorous dialogue among scientists, it contributes significantly to the ever-evolving landscape of biochemistry and genetics.

CYTOTECHNOLOGY, an esteemed journal published by Springer, stands as a vital resource in the fields of Bioengineering, Biomedical Engineering, and Biotechnology. With an impact factor reflective of its solid position within academia, this journal encompasses a broad scope dedicated to the advancement of cytotechnological research and applications from its inception in 1987 through to its latest volumes in 2024. Based in the Netherlands, it is committed to providing researchers, professionals, and students with high-quality, peer-reviewed articles that contribute to the understanding and innovations in cytotechnology. Although currently not open access, CYTOTECHNOLOGY has garnered a commendable reputation, holding Q3 rankings in multiple categories, indicating its relevance and influence within the scientific community. Researchers are encouraged to submit their cutting-edge findings to share insights that can spark further advancements in this dynamic field.

Regenerative Therapy is a premier open-access journal dedicated to advancing the fields of biomaterials, biomedical engineering, and developmental biology. Published by Elsevier in Japan, this journal has been an influential platform since its inception in 2015, contributing significantly to the global discourse on regenerative medicine. With an impressive Q2 ranking in major categories such as Biomaterials and Biomedical Engineering, it is recognized for its quality of research and innovation. Researchers seeking to disseminate their findings or explore cutting-edge developments will find Regenerative Therapy to be invaluable, reflecting current trends and fostering collaborations across interdisciplinary boundaries. The journal offers open access, ensuring that high-quality research is available to a broad audience and enhances the impact of scholarly work in the regenerative medicine community.

Stem Cell Research & Therapy is an esteemed international journal published by BMC, specializing in the rapidly advancing fields of stem cell research and regenerative therapies. Since its inception in 2010, the journal has embraced an Open Access model, ensuring that vital research is readily accessible to a global audience. With a significant impact in the scientific community, it holds Q1 quartile rankings in prestigious categories such as Biochemistry, Genetics and Molecular Biology, Cell Biology, and Molecular Medicine, highlighting its critical role in promoting groundbreaking research. The journal’s high Scopus rankings—placing it in the top echelons of its fields—reflect its commitment to publishing high-quality, peer-reviewed studies that advance our understanding of stem cell biology and therapeutic applications. Aimed at researchers, healthcare professionals, and students alike, Stem Cell Research & Therapy is an indispensable resource for those dedicated to the exploration and innovation within this transformative area of science.

Stem Cell Reviews and Reports is a prestigious journal published by SPRINGER specializing in the dynamic field of stem cell research, encompassing various aspects of cell biology and cancer research. With an ISSN of 2629-3269 and E-ISSN of 2629-3277, this journal serves as an essential resource for academics, offering insightful reviews and cutting-edge reports from 2009 to 2024. The journal has achieved a commendable Q2 ranking in both Cancer Research and Cell Biology categories as of 2023, highlighting its significant contribution to the scientific community. Additionally, with Scopus rankings placing it in the 74th percentile for both biochemistry and cell biology, it is recognized for its high-quality articles that foster innovative approaches in stem cell therapy and regenerative medicine. As an Open Access publication, Stem Cell Reviews and Reports ensures that its comprehensive content is readily available to researchers, professionals, and students, promoting collaboration and advancement in this vital area of study.